Comprehensive characterization of somatic mutations associated with chimeric RNAs in human cancers
International Journal of Cancer · 2024
DOI: 10.1002/ijc.34955 ↗At a glance
Journal article in International Journal of Cancer, 2024. Written by Yuting Wang and 5 co-authors. Institution: The Province and Ministry Co-sponsored Collaborative Innovation Center for Medical Epigenetics, Tianjin Key Laboratory of Inflammatory Biology, Tianj…. Major MEDLINE topics: Neoplasms, Mutation, RNA Splicing. 36 references. Funded by: National Natural Science Foundation of China, Natural Science Foundation of Tianjin Municipality.
Abstract (original language)
Chimeric RNAs, which can arise from gene recombination at the DNA level or non‐canonical splicing events at the RNA level, have been identified as important roles in human tumors. Dysregulated gene expression caused by somatic mutations and altered splicing patterns of oncogenes or tumor suppressor genes can contribute to the development of tumors. Therefore, investigating the formation mechanism of chimeric RNAs via somatic mutations is critical for understanding tumor pathogenesis. This project is the first to propose studying the association between somatic single nucleotide variants and chimeric RNAs, identifying around 2900 somatic SNVs affecting chimeric RNAs in pan‐cancer level. The somatic SNVs on chimeric RNAs were commonly observed in various types of tumor tissues, providing a valuable resource for future study. Additionally, these SNVs show distinct tumor specificity, and those with high frequency had a significant impact on the survival time of patients with tumors. Further research revealed that somatic SNVs associated with chimeric RNA (chiR‐SNVs) were typically found within 10 nt of the junction site of chimeric RNAs and had a particularly significant effect on chimeric RNAs from different chromosomes. The enrichment analysis revealed that chiR‐SNVs were significantly overrepresented in oncogenes and genes related to RNA binding proteins involved in RNA splicing, which could imply that chiR‐SNVs may disrupt the process of RNA splicing and induce the occurrence of chimeric RNAs. This study sheds light on the potential molecular interaction mechanism between somatic SNVs and chimeric RNAs, which opens up a new avenue for researching disease pathway and tumorigenesis development.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- The Province and Ministry Co-sponsored Collaborative Innovation Center for Medical Epigenetics, Tianjin Key Laboratory of Inflammatory Biology, Tianjin Geriatrics Institute, Tianjin Medical University General Hospital,…
- Department of Pharmacology, School of Basic Medical Sciences, Tianjin Medical University, Tianjin, China.
- Neurosurgery Department II Ward, Yidu Central Hospital of Weifang, Shandong, China.
- State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sc…
- Department of Family Planning, The Second Hospital of Tianjin Medical University, Tianjin, China.
- Department of Geriatrics, Tianjin Medical University General Hospital, Tianjin Medical University, Tianjin, China.
ORCID profiles: Yuting Wang, Yang Yang
Funding
- National Natural Science Foundation of China
- Natural Science Foundation of Tianjin Municipality
Cite
APA
Wang, Y., Shu, M., Wang, T., He, T., Yuan, J., & Yang, Y. (2024). Comprehensive characterization of somatic mutations associated with chimeric RNAs in human cancers. International Journal of Cancer. https://doi.org/10.1002/ijc.34955
Vancouver
Wang Y, Shu M, Wang T, He T, Yuan J, Yang Y. Comprehensive characterization of somatic mutations associated with chimeric RNAs in human cancers. International Journal of Cancer. 2024. doi:10.1002/ijc.34955
BibTeX
@article{Wang2024,
author = {Wang, Yuting and Shu, Meng and Wang, Tianqiang and He, Tongxin and Yuan, Jiapei and Yang, Yang},
title = {Comprehensive characterization of somatic mutations associated with chimeric RNAs in human cancers},
journal = {International Journal of Cancer},
year = {2024},
doi = {10.1002/ijc.34955}
}
EUVIMED